Blueprint Medicines Corporation
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von PR-Newswire bereitgestellt.
CAMBRIDGE, Mass., Sept. 10, 2024 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced its participation in the following upcoming virtual investor conferences:
Stifel 2024 Immunology and Inflammation Virtual Summit on Tuesday, September 17, 2024, at 2:00 p.m. ET.TD Cowen's Chronic Urticaria Summit on Friday, September 20, 2024, at 11:00 a.m. ET.
A live webcast of each presentation will be available by visiting the Investors & Media section of Blueprint Medicines' website at http://ir.blueprintmedicines.com. A replay of the webcasts will be archived on Blueprint Medicines' website for 30 days following each presentation.
LOS ANGELES, July 24, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avangrid, Inc. ("Avangrid" or "the Company") (NYSE: AGR), Squarespace, Inc. ("Squarespace" or "the Company") (NYSE: SQSP), and Blueprint Medicines Corporation ("Blueprint" or "the Company") (NASDAQ: BPMC), for potential breaches of fiduciary duty on the part of their directors and management.
LOS ANGELES, July 10, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avangrid, Inc. ("Avangrid" or "the Company") (NYSE: AGR), Squarespace, Inc. ("Squarespace" or "the Company") (NYSE: SQSP), and Blueprint Medicines Corporation ("Blueprint" or "the Company") (NASDAQ: BPMC), for potential breaches of fiduciary duty on the part of their directors and management.
LOS ANGELES, June 17, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avangrid, Inc. ("Avangrid" or "the Company") (NYSE: AGR), Squarespace, Inc. ("Squarespace" or "the Company") (NYSE: SQSP), and Blueprint Medicines Corporation ("Blueprint" or "the Company") (NASDAQ: BPMC), for potential breaches of fiduciary duty on the part of their directors and management.
LOS ANGELES, June 13, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avangrid, Inc. ("Avangrid" or "the Company") (NYSE: AGR), Squarespace, Inc. ("Squarespace" or "the Company") (NYSE: SQSP), and Blueprint Medicines Corporation ("Blueprint" or "the Company") (NASDAQ: BPMC), for potential breaches of fiduciary duty on the part of their directors and management.
